Navigation Links
Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Society's Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
Date:10/20/2009

ts

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the company to differ materially from those expressed or implied in such forward looking statements. The company undertakes no obligation to update or revise any forward-looking statements.

    Company Contact:

    Oramed Pharmaceuticals
    Tara Horn
    Cell: +972-54-334-318
    Office: +972-2-566-0001
    Email: tara@oramed.com

SOURCE Oramed Pharmaceuticals Inc.


'/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
2. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
3. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
4. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
5. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
6. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
7. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
8. /K I L L K I L L K I L L -- Oramed Pharmaceuticals Inc./
9. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
10. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
11. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... ALTO, Calif., Dec. 16 The Boards ... Corporation are delighted to announce the merger of ... the field of RNAi (RNA interference). The ... have multiple RNAi discovery, development and delivery technologies, ... a broad portfolio of intellectual property. ,, ...
(Date:12/16/2009)... CHICAGO, Dec. 16 Advanced Life Sciences ... positive top-line results from a pivotal, non-human primate ... (cethromycin) against an inhaled lethal dose of tularemia. ... survival rate at the doses tested. All ... received 16 mg/kg once-a-day of Restanza (approximate to ...
(Date:12/15/2009)... SAN DIEGO, Dec. 15 Volcano Corporation ... precision intravascular therapy guidance tools - including Fractional ... IVUS and Optical Coherence Tomography (OCT) - designed ... and peripheral vascular disease, announced today the placement ... The s5 family of consoles was first launched ...
Breaking Medicine Technology:Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 2Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 3Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 4Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 5Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 6Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 2Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 3Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study 4Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 60284 1Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 60284 2Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 60284 3Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 60284 4Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 14636 1Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 14636 2Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 14636 3Zimmer Holdings Announces OMeGA Graduate Medical Education Grant Recipients 14636 4Stryker Statement in Response to the Indictment of Its Biotech Division 14634 1Stryker Statement in Response to the Indictment of Its Biotech Division 14634 2
... Lenetix Announces Successful Study of Improved Non-invasive Test ... announced a significant step in the development of ... chromosomal screening test to detect Down syndrome and ... results at the 29th annual Society for Maternal-Fetal ...
... Cancer Caucus on Capitol Hill to Raise Awareness of ... 28 A group of radiation oncology ... awareness about one of the least understood cancer treatments: ... patients receive radiation treatment. In a patient,s personal ...
Other Medicine Technology:Breakthrough in Prenatal Screening for Down Syndrome 2Winning the War on Cancer: The Critical Role of Radiation Oncology 2Winning the War on Cancer: The Critical Role of Radiation Oncology 3
(Date:12/16/2009)... 16 Shoppers like knowing if their ... Argentina. But grocers have found it burdensome to ... laws requiring them to provide the information at ... easyCOOLnow.com for easily making grocery and ... provisions that require retailers of unprocessed fruits, vegetables ...
(Date:12/16/2009)... MassMutual,s Retirement Services Division has announced ... platform in Q2 2010. The new platform will ... investment change materials in a variety of themes. ... from a menu of creative options to support ... population. The new RetireSmart participant engagement platform will ...
(Date:12/16/2009)... Boston University School of Medicine,s (BUSM) Pulmonary ... from the National Heart, Lung, and Blood Institute ... patients with lung disease. , Darrell Kotton, ... Gustavo Mostoslavsky, MD, PhD, assistant professor of medicine, ... award. Together Kotton and Mostoslavsky lead a multicenter ...
(Date:12/16/2009)... healthcare staffing agency, is honored to announce that Chris Wepfer ... of the Year in Healthcare Traveler magazine’s 2009 Recruiters of ... Chris has received such honors and the first for Jackie. ... ... -- Medical Solutions, a national healthcare staffing agency, is honored ...
(Date:12/16/2009)... International, Inc. (OTC Bulletin Board: MZEI) ... Board of Medizone New Zealand Ltd., a joint ... 50% interest, agreed on December 14, 2009 to ... International all global marketing rights of the company,s ... Marshall said, "Time has eroded the relevance of ...
Breaking Medicine News(10 mins):Health News:New Website Helps Grocers Comply With COOL Laws 2Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 2Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 3Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 4Health News:MassMutual to Launch New RetireSmart(SM) Participant Engagement Platform 5Health News:Boston University School of Medicine's pulmonary center receives $1.4 million grant 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2
... of German and American researchers have used enetic engineering ... to transmit malaria--at least to mice, new study findings ... right direction" towards combating malaria in humans, study author ... Ohio. "We now know it is possible to genetically ...
... who suffer from premenstrual syndrome, or PMS. A new ... who have exhausted all other medications without help.// ... in Philadelphia, set out to determine whether half-cycle dosing ... started 14 days prior to the start of menstruation. ...
... vitamins may not play a role in preventing death ... believe vitamin intake could prevent cardiovascular disease, but results ... University Hospital in Switzerland and University of Miami School ... if vitamin E, vitamin C or a multivitamin could ...
... biting a bar of chocolate every day is connected to ... fat and sugar, it has long been seen as a ... based products, it also contains antioxidants, which can protect from ... now suggest that people who eat chocolate regularly are happier ...
... According to researchers, women who have had a complicated ... heart disease later on. Researchers in Glasgow, Scotland, suggest ... difficult pregnancies //- for they are at risk of ... who develop diabetes during pregnancy are at increased risk ...
... on the hazards faced during travel. People travelling in the US ... posed by outdoor adventure. Many travel experts expect people to holiday ... //An outdoor adventure holiday with lots of wildlife and sports ... hazards involved in this kind of trip, say experts at the ...
Other Medicine News:Health News: Gene researchers make Malaria-resistant mosquito 2
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Micro emulsifying needles, 18G....
Micro-Scissors "micro 2000". 12 mm, straight, extra-wide serrated handles....
... forceps "micro 2000", with ... tension light-weight instruments with ... extremely light weight, well ... fatigueless working, easy to ...
Medicine Products: